TSE:4118Chemicals
Does Kaneka’s Toro 88 Superbore Catheter Launch Deepen Its Neurovascular Ambitions For Kaneka (TSE:4118)?
Toro Neurovascular previously announced that the U.S. FDA had granted 510(k) clearance for its Toro 88 Superbore Catheter, with Kaneka Medical America LLC leading the U.S. commercial launch following the device’s first successful clinical use by Dr. Satoshi Tateshima.
This launch underscores Kaneka’s deeper involvement in the neurovascular device market, pairing Toro’s catheter technology with Kaneka’s established U.S. sales and clinical support network.
We’ll now examine how Kaneka’s role...